C. Liang
发表
J. Christensen,
R. Salgia,
Yuri B. Pride,
2003
.
C. Liang,
Hui Chen,
Li Sun,
2002,
Bioorganic & medicinal chemistry letters.
G. Mcmahon,
C. Liang,
B. Jallal,
2003,
Bioorganic & medicinal chemistry.
C. Liang,
L. C. Allen,
1991
.
C. Liang,
J. Hill,
Jörg-Rüdiger Hill,
1997
.
H. Schaefer,
N. L. Allinger,
P. Schleyer,
1992
.
H. Schaefer,
C. Liang,
B. Duke,
1991
.
A. Hagler,
T. Stouch,
C. Liang,
1994
.
C. Liang,
L. C. Allen,
1991
.
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
Cherrington,
R A Blake,
S. Hubbard,
2000,
Cancer research.
C. Liang,
L. C. Allen,
1990
.
H. Schaefer,
C. Liang,
M. Shen,
1993
.
H. Schaefer,
C. Liang,
R. Davy,
1989
.
H. S. Kim,
H. Schaefer,
C. Liang,
1991
.
Congxin Liang,
H. Schaefer,
C. Liang,
1990
.
H. Schaefer,
C. Liang,
1990
.
M. Newton,
C. Liang,
1992
.
Terry R. Stouch,
Arnold T. Hagler,
Congxin Liang,
1993
.
Terry R. Stouch,
Arnold T. Hagler,
Jörg-Rüdiger Hill,
1995,
J. Comput. Chem..
H. Schaefer,
T. Hamilton,
C. Liang,
1990
.
A. Howlett,
G. Mcmahon,
C. Liang,
2003,
Molecular cancer therapeutics.
G. Mcmahon,
S. Lim,
D. Schlaepfer,
2010,
Cancer biology & therapy.
J. Christensen,
R. Salgia,
P. Ma,
2003,
Cancer research.
G. Mcmahon,
C. Liang,
Li Sun,
2000
.
L. Schmidt,
A. Howlett,
D. Candinas,
2004,
Oncogene.
S. Honsawek,
G. Mcmahon,
C. Liang,
2001
.
S. Hubbard,
A. Ullrich,
N. Shenoy,
2000
.
S. Hubbard,
A. Ullrich,
N. Shenoy,
2000
.
Congxin Liang,
M. Newton,
C. Liang,
1993
.
C. Liang,
L. C. Allen,
1988
.
C. Liang,
L. C. Allen,
1987
.
G. Mcmahon,
L. Sun,
C. Tang,
1999,
Journal of medicinal chemistry.
L. Ellis,
C. Liang,
J. Cherrington,
2000,
Anti-cancer drug design.
C. Liang,
Yongbin Ma,
Yang Wang,
2020,
Zhongguo fei ai za zhi = Chinese journal of lung cancer.